skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: DOAJ Directory of Open Access Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections
1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections

Brown, Michelle ; Motsch, Johann ; Kaye, Keith ; File, Thomas ; Boucher, Helen W ; Vendetti, Neika ; Aggrey, Angela ; Joeng, Hee-Koung ; Tipping, Robert ; Du, Jiejun ; Depestel, Daryl D ; Butterton, Joan ; Kartsonis, Nicholas A ; Paschke, Amanda

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S563-S563 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
2
1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections
1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections
Material Type:
Artigo 		Adicionar ao Meu Espaço

1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients with Imipenem-Nonsusceptible (NS) Bacterial Infections

Kaye, Keith ; File, Thomas ; Boucher, Helen W ; Brown, Michelle ; Aggrey, Angela ; Khan, Ireen ; Joeng, Hee-Koung ; Tipping, Robert ; Du, Jiejun ; Young, Katherine ; Butterton, Joan ; Kartsonis, Nicholas A ; Paschke, Amanda

Open forum infectious diseases, 2018-11, Vol.5 (suppl_1), p.S409-S409 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
3
Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests
Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests

Jean, Shio-Shin ; Hsieh, Tai-Chin ; Hsu, Chin-Wan ; Lee, Wen-Sen ; Bai, Kuan-Jen ; Lam, Carlos

Journal of microbiology, immunology and infection, 2016-12, Vol.49 (6), p.924-933 [Periódico revisado por pares]

England: Elsevier B.V

Texto completo disponível

Citações Citado por
4
Imipenem/Cilastatin/Relebactam for Complicated Infections: A Real-World Evidence
Imipenem/Cilastatin/Relebactam for Complicated Infections: A Real-World Evidence
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imipenem/Cilastatin/Relebactam for Complicated Infections: A Real-World Evidence

Sansone, Pasquale ; Giaccari, Luca Gregorio ; Di Flumeri, Giusy ; Pace, Maria Caterina ; Pota, Vincenzo ; Coppolino, Francesco ; Brunetti, Simona ; Aurilio, Caterina

Life (Basel, Switzerland), 2024-05, Vol.14 (5), p.614 [Periódico revisado por pares]

Switzerland: MDPI AG

Texto completo disponível

Citações Citado por
5
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial
Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early use of imipenem/cilastatin and vancomycin followed by de-escalation versus conventional antimicrobials without de-escalation for patients with hospital-acquired pneumonia in a medical ICU: a randomized clinical trial

Kim, Jong Wook ; Chung, Joowon ; Choi, Sang-Ho ; Jang, Hang Jea ; Hong, Sang-Bum ; Lim, Chae-Man ; Koh, Younsuck

Critical care (London, England), 2012-02, Vol.16 (1), p.R28-R28 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Citações Citado por
6
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients

Ozyilkan, O ; Yalçintaş, U ; Başkan, S

The Korean journal of internal medicine, 1999-07, Vol.14 (2), p.15-19 [Periódico revisado por pares]

Korea (South): Korean Association of Internal Medicine

Texto completo disponível

Citações Citado por
7
Imipenem - Cilastatin versus Sulbactam - Cefoperazone plus Amikacin in the Initial Treatment of Febrile Neutropenic Cancer Patients
Imipenem - Cilastatin versus Sulbactam - Cefoperazone plus Amikacin in the Initial Treatment of Febrile Neutropenic Cancer Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Imipenem - Cilastatin versus Sulbactam - Cefoperazone plus Amikacin in the Initial Treatment of Febrile Neutropenic Cancer Patients

Ozgur Ozyilkan ; Ulku Yalcintas ; Sezgin Baskan

The Korean journal of internal medicine, 1999-07, Vol.14 (2), p.15 [Periódico revisado por pares]

대한내과학회

Texto completo disponível

Citações Citado por
8
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study
Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study

Brown, Michelle L ; Motsch, Johann ; Kaye, Keith S ; File, Thomas M ; Boucher, Helen W ; Vendetti, Neika ; Aggrey, Angela ; Joeng, Hee-Koung ; Tipping, Robert W ; Du, Jiejun ; DePestel, Daryl D ; Butterton, Joan R ; Paschke, Amanda

Open forum infectious diseases, 2020-03, Vol.7 (3), p.ofaa054 [Periódico revisado por pares]

US: Oxford University Press

Texto completo disponível

Citações Citado por
9
MSC-derived exosomal miR-140-3p improves cognitive dysfunction in sepsis-associated encephalopathy by HMGB1 and S-lactoylglutathione metabolism
MSC-derived exosomal miR-140-3p improves cognitive dysfunction in sepsis-associated encephalopathy by HMGB1 and S-lactoylglutathione metabolism
Material Type:
Artigo 		Adicionar ao Meu Espaço

MSC-derived exosomal miR-140-3p improves cognitive dysfunction in sepsis-associated encephalopathy by HMGB1 and S-lactoylglutathione metabolism

Ma, Ying ; She, Xingguo ; Liu, Yang ; Qin, Xian

Communications biology, 2024-05, Vol.7 (1), p.562-13, Article 562 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram-negative bacteria: A real-life study
Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram-negative bacteria: A real-life study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram-negative bacteria: A real-life study

Larcher, Romaric ; Laffont-Lozes, Paul ; Roger, Claire ; Doncesco, Regine ; Groul-Viaud, Celine ; Martin, Aurelie ; Loubet, Paul ; Lavigne, Jean-Philippe ; Pantel, Alix ; Sotto, Albert

Frontiers in cellular and infection microbiology, 2022-12, Vol.12, p.1048633 [Periódico revisado por pares]

Switzerland: Frontiers

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (723)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (727)
  2. Resenhas  (2)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2003  (7)
  2. 2003Até2007  (17)
  3. 2008Até2012  (48)
  4. 2013Até2018  (160)
  5. Após 2018  (498)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (727)
  2. Japonês  (40)
  3. Português  (11)
  4. Turco  (3)
  5. Chinês  (1)
  6. Coreano  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.